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A survey of physicians implanting pacemakers was con-
ducted to obtain a profile of permanent cardiac pacing
practices in the United States during 1981. Question-
naires were mailed to 5,832 implanters with 765 re-
sponses (13%) received and 680 analyzed. It was esti-
mated that there were approximately 5,600 physicians,
66% surgeons and 34% nonsurgeons, implanting pace-
makers at 3,670 centers. About 118,000 new primary
implants were performed, or 518 per million population.
Only 17% of implantation procedures in 1981 were re-
placements compared with 31% in 1978. Roughly half
the respondents worked in teams, most implanting from
46 to 55 pacemakers annually.
The chief indications for permanent pacing were sick
sinus syndrome (48%) and impairment of conduction in
the atrioventricular node and His-Purkinje system (42%).
Ninety-five percent of pacing leads were implanted trans-
venously. Seventy percent of the respondents had had
Since 1969, the results of a series of worldwide surveys of
cardiac pacing practices have been reported at the triennial
(now quadrennial) World Symposium on Cardiac Pacing.
The world was divided into geographic pacing regions, in-
cluding western Europe, the Far East, Africa, South Amer-
ica and the United States and Canada. The senior author
has been responsible for the United States portion of the
surveys since the first survey.
Earlier surveys have disclosed numerous trends in pac-
ing. Until now, the most important of these have been re-
lated to the total number of primary pacemaker implants
and replacements and the gradual changes in indications for
pacing and implantation techniques. In 1978, pacemakers
were implanted in the United States at a rate of 309 per
million population; transvenous implantations were used by
95% of the responding physicians, and ventricular demand
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experience with atrial and dual-chamber pacemakers,
used largely to increase cardiac output. The use of ven-
tricular demand (VVI) pacing decreased accordingly from
91% in 1975 to 84% in 1981. Although approximately
90% of primary pacemakers were programmable to some
degree, almost half were not reprogrammed within the
first 3 months after implantation and 30% were never
reprogrammed. Most patients (85%) were followed up
by transtelephonic electrocardiographic monitoring, 68%
in conjunction with private office visits. The respondents
estimated that dual-chamber pacing, accounting for 10%
of implants in 1981, would increase to 37% by 1985.
Early electrode malfunctions were less frequent when
implantation was performed by high volume and solo
implanters, and in public and community hospitals. It
is concluded that periodic surveys of this type disclose
important trends in the practice of cardiac pacing.
(VVl) pacing was the pacing mode chosen in almost every
case. Such information has proven useful to physicians,
pacemaker manufacturers and third party insurance carriers,
who have begun to scrutinize the impact of new develop-
ments in pacing on the health care dollar.
The results of the present survey were obtained from
responses to a questionnaire distributed in 1982 to pace-
maker implanters that requested data from the preceding 12
month period (1981). Data are now available on pacing
practices for the years 1969, 1972, 1975, 1978 and 1981,
not only for the United States but for much of the world
(1-6). In addition to frequencies and percents, this survey
included a first attempt at gathering some evidence con-
cerning the quality of work performed and attitudes toward
noninvasive pacemaker programming and use of more com-
plex dual-chamber pacemakers.
Methods
Sampling mailing lists. Sampling for this survey pre-
sented a special problem in that there exists no complete
list of physicians implanting pacemakers. Therefore, a two-
stage sampling design was employed to obtain a sample of
0735-1097/84/$300
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physicians that would approximate the larger pacing
community.
The American Hospital Association provided mailing la-
bels for every hospital in the country. Four groups of hos-
pitals were classified: those within or outside a Standard
Metropolitan Statistical Area (SMSA) (7,8) and those with
or without more than 100 beds. Because it was assumed
that pacemakers would probably be implanted at most large
urban hospitals (more than 100 beds and within an SMSA),
each hospital in this group was asked to provide the names
of all physicians implanting pacemakers at that institution.
An additional 457 hospitals from the other three groups were
randomly selected for inclusion. These included hospitals
with fewer than 100 beds within an SMSA and hospitals
outside an SMSA with and without at least 100 beds. The
entire sample consisted of 3,210 hospitals.
As in our previous surveys, pacemaker manufacturers
were asked to provide their physician mailing lists; all but
one complied. Names obtained from these lists were com-
bined with those provided by the hospitals.
Questionnaire. The main body of the II page ques-
tionnaire was designed to elicit 1981 (and some 1979 and
1980) data on caseload, indications for pacing, epidemiol-
ogy, operative techniques, pacing modes, programming and
follow-up techniques, along with selected projections for
1985. Five supplementary questions were included regard-
ing pacemaker reuse, rhythm disturbances, electrocardio-
graphic indications for pacing, the potential usefulness of
an automatic implantable defibrillator and the incidence of
neoplasm observed in tissue in contact with an implanted
pulse generator or lead. Although many questions were in-
cluded because of our own research interests, others were
included at the request ofthe organizers of the World Survey
on Cardiac Pacing (6).
The United States Survey on Cardiac Pacing was sent
initially to 7,000 physicians. It was mailed to the entire
physician population, that is, to each physician on the list,
whether an implanter or a referring physician (the manu-
facturers' lists made no such distinction). A postcard re-
minder was sent to each nonrespondent approximately 6
weeks after the initial mailing. In addition, a special short
form of the questionnaire containing a subset of the original
questions was prepared to simplify the collection of data
from "important" but reluctant respondents. Because we
were especially interested in New Jersey physicians, 180
abridged "New Jersey Surveys" were mailed to these phy-
sicians in addition to the main survey. Finally, all New
Jersey nonrespondents were contacted by telephone, and
some additional data were obtained.
Data analysis. Data analysis consisted primarily of cal-
culated marginal percents and percents for various subsets
of physicians (for example, surgeons and nonsurgeons). In
addition, chi-square tests of association were performed to
find statistically significant differences among subsets of
physicians. TACTICS, a statistical package available through
COMSHARE, a computer time-sharing service, was used
for all data analysis.
Because of the length and complexity of the survey in-
strument, there were many missing data points. Some of
the data were not available and some were difficult for
respondents to provide without an extensive review of pa-
tient records. Although physicians were asked to provide
information relative to their own pacing practices only, many
responded for a group of implanters at their particular in-
stitution or for an entire group practice. This made it im-
possible to adhere to the original design, which had specified
the individual as the unit of analysis. Thus, in some in-
stances, an entire group had to be "counted" as an indi-
vidual physician. Because it was often impossible to identify
which questionnaires represented a single individual's prac-
tice and which represented groups of physicians, there was
no way to exclude group responses.
Results
Response rates. The response rate from hospitals was
35%. Of the 3,210 letters sent, 285 (9%) were returned
marked "pacemakers are not implanted at this institution."
Almost a third of the hospitals provided us with the names
of staff physicians who implanted pacemakers. * From post-
card returns, we were able to estimate roughly the number
of hospitals in which pacemakers were implanted. Our es-
timate of 3,676 "implanting hospitals" is consistent with
manufacturers' estimates of 2,200 to 4,000,
Questionnaires were ultimately mailed to 7,000 physi-
cians. Two hundred sixteen questionnaires were returned
by the post office as undeliverable, and 952 physicians (13.1%
of the total sample) returned the survey stating that they did
not implant pacemakers. With these two groups excluded,
5,832 presumably valid names and addresses remained. Four
hundred ninety-five physicians (more than 8% of the re-
maining sample) declined to participate; 765 (13%) of the
surveys were completed and returned. Eighty-five responses
were received too late to be included in the computer analysis.
Demographics. We estimate that in 1981 there were
approximately 5,600 physicians implanting pacemakers at
3,670 centers in the United States. Sixty-six percent of
*Some hospital boards and associations. evidently deluged with survey
requests. have developed an interesting method of dealing with such re-
quests. We received many letters stating that the local hospital association
required that we complete their questionnaire. The letter stated that if we
would complete and return the questionnaire. our request would be placed
on the association's agenda and reviewed at its next meeting. If approved,
the particular hospital would be happy to complete our "survey." The
irony is that many of their "counter-questionnaires" were five or six pages
long! All we had asked was that a postcard be returned listing the name
and address of the hospital, whether or not pacemakers were implanted
there and, if so. who implanted them.
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physicians implanting pacemakers were surgeons (mostly
general and thoracic) and 34% were nonsurgeons (mostly
cardiologists). The respondents had been in practice for a
mean of 13.3 years, and were implanting pacemakers for a
mean of 11,0 years. The majority (53%) were in private
practice or with a single specialty group (24%). Twenty-
three percent taught either full- or part-time, but only 3%
were engaged in research.
The "typical" pacemaker implanter worked at two hos-
pitals, primarily relatively large (median bed size 379), pri-
vate (36%) and community (44%) hospitals, and worked as
part of a team of physicians (the mean size of the "implant
team" was 1.6 physicians) approximately half the time (this
was a bimodal distribution: 39% "never" and 39% "al-
ways" worked in a team), The typical physician had im-
planted a mean of 327 pacemakers during his or her medical
career, and had implanted 37 to 40 primary and 9 to II
replacement pacemakers during 1981.
We arbitrarily defined a "busy" implanter as one who
implanted 30 or more pacemakers a year. Typically, the
individual was in a private practice that was not hospital-
based. Such a physician was likely to use dual-chamber and
atrial pacemakers and multiprogrammable pacemakers, fa-
vor the reuse of pacemakers and reject the assistance of a
manufacturer's sales representative at the operating table.
Growth of pacing (Fig. 1). Most centers began pace-
maker implantation during 1969, yet 75% did not have a
special pacemaker department or service, and only 54% had
"specific written guidelines governing surgical privileges
for pacemaker implantation." The yearly number of new
pacemaker implants grew from 66,724 in 1978 to 117,800
in 1981, increasing from 309 to 518 new implants per mil-
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lion population. Replacement units decreased markedly, from
31% of the total implants in 1978 to 17% in 1981.
Indications for pacing (Fig. 2). Sick sinus syndrome,
which accounted for 23% of indications in 1975, increased
to 48% in 1981. The respondents did not expect this increase
to continue, estimating that sick sinus syndrome would ac-
count for 45% of pacing indications in 1985. Decremental
atrioventricular (AY) conduction at the level of the AY node
and His-Purkinje system as an indication for pacing de-
creased steadily from 59% in 1975to 42% in 1981. A further
decrease to 35% was anticipated by 1985,
Pacemaker implantation for the treatment of tachyar-
rhythmias was expected to increase only slightly, from 1.9%
in 1981 to 3.9% by 1985. The largest increase in indications,
however, was expected in the category of "other" indi-
cations (8 to 16%). It is unclear what the respondents meant
by "other."
Pacing technique. Ninety-five percentof pacemaker leads
were implanted transvenously. The standard cut-down tech-
nique was used in 73% of cases, and an introducer was used
at times by 50% of the respondents. The procedures were
performed in the operating room in 58% of cases, the cath-
eterization laboratory in 24%, the X-ray department in 14%
and a special procedures room or "other" facility in 5%.
Sutures were used to affix pulse generators to the sur-
rounding tissue in 42% of cases, and a cloth cover was
employed in 6%. (Comparable 1978 figures were 34 and
9%, respectively.) Thus, pulse generators were affixed to
the surrounding tissue in some way in about 50% of cases,
an increase from the 37% reported for 1978.
Pacing modes and leads. Figure 3 shows the change in
the use of dual-chamber (DYI, DOD and YDD) and single-
Figure I. The trend in implantation rate during the 13
year period from 1969 to 1981, showing an increase of
roughly 38 implants per million population each year.
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Figure 2. Relative frequency of indications
for permanent cardiac pacing during the 10
year period from 1975 to 1985. A-V =
atrioventricular.
Figure 3. Relative frequency of pacing modes se-
lected for primary pacemaker implants during the
10 year period from 1975 to 1985.
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chamber (VVl) pacemakers* from 1975 to 1981, together
with projections for 1985. Single-chamber pacemaker usage
decreased from 91% in 1975 to 84% in 1981 and is expected
to decrease even further to 54% by 1985. The use of dual-
chamber pacemakers increased from 0.2% in 1975 to 9.4%
in 1981. The prediction for 1985 was 37%. Thirty percent
of the respondents did not use atrial or dual-chamber sys-
tems, either because such a system had not been requested
by the referring physician or because the implanter did not
have enough experience to use them. Twenty percent be-
lieved that there was little need for dual-chamber and atrial
pacing. The 70% who reported using atrial and dual-cham-
ber systems chose them primarily to increase cardiac output.
*YYI and other symbolic representations of pacing modes used in this
report are taken from a code introduced in 1974 by the Inter-Society
Commission for Heart Disease Resources (9). YDD is a pacing mode in
which spontaneous atrial depolarizations are sensed and the ventricle is
paced after a suitable AY interval (atrial synchrony). This mode provides
variable rate ventricular pacing consistent with physiologic need. A YDD
pacemaker has the additional advantage of sensing ventricular depolari-
zations, so that premature spontaneous ventricular beats will inhibit the
next pacemaker output (demand function). In the DYI pacing mode, both
chambers are paced in sequence, but spontaneous atrial events are not
sensed. In other words, it is nonadaptive dual-chamber demand pacing
with the ventricle stimulated at a fixed rate unless the pacemaker is inhibited
by spontaneous ventricular activity. DDD is the most sophisticated pacing
mode, providing the AY stimulation sequence of dual-chamber pacing,
the rate adaptivity of atrial synchrony and the demand features of atrial
and ventricular inhibition.
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Table 2. Management of Pacemaker Programming, 1981
by the implanting physician in 51% of cases and by a follow-
up physician in 23%. Referring physicians, nurses, pace-
maker technicians and manufacturers' sales representatives
combined performed 14% of pacemaker programming
procedures.
Follow-up. Sixty percent of the respondents followed
up fewer than 100 patients in their own practice. About the
same number of patients were followed up in hospital pace-
maker clinics (in 60% of hospitals there was no pacemaker
clinic), but of the 40% whose patients were followed up in
such a clinic, 50% reported following up 100 or fewer
patients in this manner. An additional 20% followed up 10I
to 200patients;only I% followed up more than 1,000patients.
Transtelephonic electrocardiographic monitoring was used
as part of the follow-up procedure by nearly every survey
respondent during 1981, only slightly more than in 1978
(85 and 81%, respectively). Of t~~ 15ro who did not use
this technique, clinic follow-up .W.-ilS PI.~ferred by 47%. Of
the nonusers, 26% believed it -to be_J.lllnecessary and 23%
considered it too costly.
The percent of patients being monitored by telephone
increased from 51% in 1978 to 60% in 1981. Telephone
follow-up was most commonly used in conjunction with
private office visits (68%). with clinic visits (30%) and in
special circumstances such as infirmity and distance (31%).
These fi gures are almost identical to those in the 1978 re-
ports. Twenty-two percent used transtelephonic electrocar-
diographic monitors for arrhythmia monitoring and 8% used
it exclusively. Most patients (29%) were provided with mon-
itors that transmitted the electrocardiographic signal and the
stimulus duration. Monitors that transmitted the electrocar-
diographic signal alone were used by 28% of patients; rate-
only transmitters were used by 3%.
The number of follow-up contacts has increased since
1978 (Table 3). The increasing frequency of follow-up was
most apparent in the firstyear after implantation, particularly
Although these systems are reported to have other clinical
benefits, the respondents did not consider those to be of
equal importance.
Lead preference has shown no consistent pattern since
/975. although unipolar leads have been preferred by most
physicians for many years. Half of the respondents ex-
pressed a preference for unipolar leads in 1975 . and three-
quarters did so in 1978. By 1981, however, the preference
for unipolar leads had decreased to 62%, and a further
decrease to 54% was anticipated by )985.
Programmability. The use of programmable pace-
makers has been steadily increasing. In 1978, 39% of the
survey respondents usedprogrammablepacemakers. By 1981 ,
90% of the implanting physicians used either simple pro-
grammable (16%) or multiprogrammable (74%) pace-
makers. Almost 10% of the primary pacemakers implanted
during 1981 were, however, nonprogrammable, but few
respondents (n = II ) explained this preference. Those who
provided an explanation felt that a nonprogrammable VVI
pacemaker was adequate.
Almost half (47%) of the programmable pacemakers im-
planted were not reprogrammed within the first 3 months
after implantation; 35% were not reprogrammed within the
first 12 months and 30% were never reprogrammed. Never-
theless, most respondents believed that multiprogrammable
pacemakers were "clinically important," especially for young
patients (Table I). Multiprogrammability was considered
useful, primarily for troubleshooting pacemaker problems
as ranked by respondents on a 4 point scale (I = very
useful, 4 = not useful). An average usefulness score of 1.7
was assigned to troubleshooting, followed closely by ad-
justment for physiologicneeds, which was scored 1.8. Mul-
tiprogrammabilitywas considered least useful for' 'fine tun-
ing" after implantation, receiving a score of 2.4.
The management of pacemaker programming is sum-
marized in Table 2. Pacemakers were most frequently pro-
grammed immediately after implantation (29%) and when
there was an apparent problem (38%). Programming was
performed in the physician' s office and in a hospital facility
(other than a pacemaker clinic) at almost the same rate (26
and 29%, respectively). Pacemaker clinics were used less
frequently (1 8%). Pacemaker programming was performed
Table 1. Respondents' Assessment of Clinical Importance of
Multiprogrammable Pacers in Relation to Patient Age. 1981
(n = 533 to 579*)
Moderately Slightly
Patient Important Important Important Unimportant
Age (yr) (%) (%) (%) (%)
:£20 84 II 3 2
21 to 50 75 18 5
51 to 70 48 37 14 2
~7 1 37 29 27 7
*Numbers vary because not all respondents answered the same set of
questions; omissions varied from respondent to respondent.
When performed
Immediately after implantation
Routinely at a fixed date
Troubleshooting
Other
Where performed
Physician' s office
Pacemaker clinic
Other hospital facility
Elsewhere
Performed by
Implanting physician
Follow-up physician
Referring physician
Nurse or pacemaker technician
Sales representative
(%)
29
21
38
I
26
18
29
4
51
23
4
8
2
1326 PARSONNET ET AL.
1981 U.S. PACING SURVEY
lACC Vol. 3, No. 5
May 1984:1321-32
Table 3. Follow-up Contacts; First 5 Years After Implantation
Office Visits Clinic Visits
Transtelephone
Monitoring
Year Contact Contact Contact
Postimplant 1978 1981 Change 1978 1981 Change 1978 198 1* 1981t Change
I 3.3 4.9 + 1.6 2.7 4. 1 +2 .8 5.9 7.7 8.3 + 10. 1
2 2.7 3.3 +0.6 2.4 2.8 + 0.4 7.4 7.4 9.0 +9.0
3 2.9 3.3 +0.4 3.0 2.8 - 0 .2 13.0 7.8 8.8 +3.6
4 3:0 3.4 +0.4 2.9 3.0 +Q. I 17.6 9. 1 10.0 + 1.5
5 3.4 4.0 +0.6 3.1 3.5 +0.4 19.4 9.7 11.9 +2.2
*Hospital or office-based telephone service; t proprietary service.
Table 4. Factors Influencing Pacemaker Choice, 1981
in the use of transtelephonic electrocardiographic monitor-
ing. If the two telephonic monitoring categories specified
in the 1981 survey are treated as subset s of the more general
category used in the 1978 survey, then the greatest change
reflected in Table 3 is in the frequency of telephone contacts.
.Pacemaker choice (Table 4). Half of the respondents
report ed that the manufacturer had a "great influence" on
their' choice of pacemaker , but more than half said that
factors 'other than those listed in the questionnaire exerted
" great influence " over their choice. In descending order of
importance were the sales representative , warranty and peer
recommendation. When asked to rank the areas of useful-
ness of the manufacturer' s sales representati ve , the respon-
dents listed their choices in the following descending order:
new product information , pacemaker education and tech-
nical advice , assistance in programming and assistance at
the operating table. The sales representative was considered
least useful in follow-up .
Pacemaker reutilization. The great majority of respon-
dents favored the reutilization of pacemakers, with 82%
believing that lithium pacemakers should sometimes be reused.
Refurbishing and resterilization by the manufacturer were
preferred by 74% ; however, an additional 17% thought that
resterilization either by the manufacturer or in-house was
acceptable . In fact , 60 respondents indicated that they have
resterilized and reused an average of 12.5 pacemakers (a
total of 750), and 32 respondents have made an average of
9. 2 pacemakers (a total of 295) available for use by others ,
Implant volume. Evidence was sought to show differ-
ences in practice pattern s in various subsets of physicians,
Manufacturer
Sales representative
Warranty
Other factors
Price
Peer recommendation
Great or Some
Influence (%)
89
74
70
70
64
56
Little or No
Influence (%)
10
25
28
17
35
43
such as surgeons versus nonsurgeons and teams versus solo
implanters. In general, surgeon s tended to be busier (in
terms of the number of procedures they performed) than
nonsurgeons during 1980 and 1981. Using 50 or !TI0re im-
plants as an index , 23 and 19% of surgeons and nonsur-
geons, respectively, implanted more than 50 pacemakers
during 1980, compared with 20 and 16%, respectively, dur-
ing 1981 (chi-square [K] = i5.05, p = 0.005 for the 1981
data).
Solo practitioners versus team members. Similarly, solo
practitioners implanted more pacemakers than did teams.
These figures, too, were significant (p = 0 .002 for both
1980 and 1981 data). Nonsurgeons worked most frequently
in teams of two or more physicians; 67% of nonsurgeons
and 47% of surgeons worked in teams (K = 20.85 , p =
0.001). Moreover , implantation teams were most common
in medical schools and private hospitals. Eight y-one percent
of physicians working in medical schools implanted pace-
makers as part of a team, compared with 52% of those not
working in medical school facilit ies ci = 13.94, P =
0.001) . Sixty percent of private hospital physicians im-
planted pacemakers as part of a team , whereas 44% of those
not working in a private hospital worked in teams (K =
16 .65 , p = 0.001) .
Nonprogrammable versus programmable pacemakers.
" Heavy" implanters (defined arbitrarily as those implanting
more than 30 pacemakers per year) used more multipro-
grammable pacemakers than did " light" implanters (those
implanting fewer than 31 pacemakers per year). Seventy-
seven percent of the former used multiprogrammable pace-
makers in more than 50% of their cases, compared with
65% of the latter (p = 0.001 ). Similarly, solo implanters
used more multiprogrammable pacemakers than did im-
plantation teams (74 and 65%, respectively; p = 0.~6) .
For surgeons, the use of both nonprog rammable and mul-
tiprogrammable pacemakers was significantly related to im-
plant volume. These relat ions were not statisticall y signif-
icant for nonsurgeons . Surgeons with a low volume of
pacemaker implantations implanted more nonprogrammable
(12% implanted more than 50%, compared with 9% for
physicians implanting a high volume of pacemakers) and
Table5. Early Endocardial Electrode Malfunction as Related to
Electrode Type, 1981
as an indicator of the quality of electrode implantation. It
wasmeasured as an interval level variableand was redefined
as ordinal for analytic purposes; malfunction was arbitrarily
considered to be low if it occurred in 5% of cases or less,
and high if greater than 5%.
For the entire sample, no category of malfunction ex-
ceeded 4.2%. In fact, the malfunction rate for neither the
ventricular graspingnor the atrial graspingelectrodereached
1.0%.
Relation to physician specialty and implant volume (Ta-
ble 6). The malfunction rate for ventricular grasping elec-
trodes approached significance when related to physician
specialty only for low volume implanters. Malfunction of
ventricular grasping electrodes was highest for surgeons,
5% of whom experienced a rate of more than 5%, while
only 0, I% of nonsurgeons reported a malfunction rate this
high (K = 2.18, p = 0.13).
Low volume implanters reported a significantly greater
degree of malfunctionof ventricularnongrasping electrodes
than did those implantingmore than 30 pacemakers per year,
regardless of physician specialty. At least a 6% electrode
malfunction rate was experienced by 22% of low volume
implanters and 7% of high volume implanters (K :::: 20.71,
P = 0.001). When physician specialty was held constant,
these differences between low and high volume implanters
persisted. Almost 21% of low volume surgeons experienced
a malfunctionrate of more than 5% comparedwith 7% from
high volume surgeons (K :::: 11.32, p = 0.001). Similarly,
23% of low volume nonsurgeons reported a malfunction
rate of at least 6% compared with 6% of high volume non-
surgeons (K = 6.50, p = 0.011).
Size ofimplantation teams. The malfunction rate for ven-
tricular nongrasping electrodeswas also significantly related
to the size of the implantation team. Twentypercentof team
physicians versus 12% of solo physicians reported a mal-
function rate of more than 5% (K :::: 5.72, p = 0.017).
When implant volume was held constant, this relation re-
mained only for low volume implanters. Team physicians
again experienced a higher rate of malfunction, with 26%
of team physicians and 16% of solo physicians reporting a
malfunction rate of more than 5% (K = 3.51, P = 0.06).
The relation between malfunction rate and the number of
physicians on the implantation team was not significant for
high volume implanters.
When the number of physicians on the implantation team
was held constant, the relation between malfunction rate
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fewer multiprogrammable (63% surgeons implanted more
than 50% with a low volume, compared with 76% for phy-
sicians with a high volume) pacemakers than did surgeons
with a high volume, The relation between volume and per-
cent of nonprogrammable pacemakers yielded a chi-square
value of 8.82 (p :::: 0.032); between volume and percent
multiprogrammable pacemakers, the chi-square value equaled
8.12 (p :::: 0.002).
For low volume implanters, a statistically significant re-
lation was found between percent nonprogrammable pace-
makers implanted and the number of physicians on the im-
plant team (K :::: 8.12, p :::: 0,044) and between percent
simple programmable pacemakers implanted and the num-
ber on the implant team (K :::: 7.86, p = 0,049). For this
group, solo physicians implanted a higher percent of non-
programmable pacemakers (12% implanted more than 50%
nonprogrammable pacemakers) than their team counterparts
(8% of whom implanted more than 50% nonprogrammable
pacemakers). Low volume team implanters, however, used
a higher percentof simpleprogrammable pacemakers. Nine-
teen percent of solo physicians and 24% of team physicians
implantedmore than 50%simpleprogrammable pacemakers
in 1981.
Pacing mode. The use of DVI pacemakers was related
to the number of years of physician practice. Physicians
who had been in practice for more than 10 years used more
DVI pacers in 1981 than did those who had been in practice
10 years or less. Of the respondents in practice for more
than 10 years, 8% had used DVI pacemakers in more than
50% of implantations, comparedwithonly 4% of physicians
in practice for 10 years or less. This relation approached
statistical significance (K :::: 6.53, p :::: 0.08).
Teachers and researchers used fewer VVI pacemakers
than did those not involved in research or teaching. The
VVI mode was used in most cases by 88% of teachers and
by 93% of nonteachers (K :::: 8.59, p = 0.035). Research-
ers implantedfewer VVI pacemakers than did teachers, with
72% of researchers using the VVI mode in most cases. For
those not involved in research, 92% used the VVI mode in
most cases (K = 8.93, p = 0.03).
Private practitioners implanted more DVI pacemakers
than did physiciansin other typesof practice. Multispecialty
groups used a higher percent of AAI (atrial demand) pace-
makers. More than 12%of private practitioners (versus 3%
of those not in private practice) used DVI pacemakers in
more than half of their cases (K :::: 9.33, p = 0.025). Of
physicians practicing with a multispecialty group, 20% used
the AAI mode in most cases. This is the only group in the
sample that reported such a high percent of AAI pacemaker
usage (K = 13.85, p = 0.001).
Electrode malfunction (Table 5). The incidence of early
endocardial electrode malfunction (dislodgment, perfora-
tion. dislocation or displacement) of ventricular and atrial
graspingand nongrasping electrodeswas measuredand used
Electrode Type
Ventricular
Atrial appendage
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(o/c)
0.9
0.7
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Nongrasping
(o/c)
4.2
3.0
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Table 6. Early Endocardial Electrode Malfunction as Related to Implant Volume. 1981
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Fewer Than 31 Implants per Year More Than 30 Implants per Year
Incidence of
ventricular
nongrasping
malfunction
oto 5%
60/,
All
78.2%
21.8%*
Surgeons
79.40/(
20.60/,*
Nonsurgeons
77.I°1c
22.90/,'[
All
92.S'ii
7.2%
Surgeons
92.6%
7.4(1<
Nonsurgeons
93.6%
6.49<
*p = 0.001; tp = 0.011.
and implant volume was not significant for solo physicians.
For team physicians, however, the relation remained sig-
nificant. Almost 26% of low volume team implanters re-
ported a malfunction rate of more than 5%, while only 10%
of high volume implanters did so.
Veterans Administration (VA) hospitals. These hospitals
experienced more frequent malfunction of ventricular non-
grasping electrodes than did other types of institutions. In
the VA hospitals, team implanters and nonsurgeons reported
considerably more malfunctions of ventricular nongrasping
electrodes than did surgeons and solo implanters.
Of all physicians who worked primarily in VA hospitals,
38% reported a malfunction rate of more than 5%, compared
with 15% of those listing another hospital type as their
primary institution C~ = 6.66, P = 0.009). Forty-five
percent of team physicians working in VA hospitals (versus
18% team physicians in other types of hospitals) reported
amalfunctionrateofmorethan5%Ci = 6.66,p = 0.019).
For nonsurgeons in VA hospitals, the proportion reporting
a malfunction rate of more than 5% increased to 46%, com-
pared with 16% of nonsurgeons not working in VA hospitals
(p = 0.019)
Grasping versus nongrasping electrodes. Grasping elec-
trodes were defined as those with active fixation elements,
such as screws or barbs. Tined leads were considered to be
nongrasping. There was a moderate correlation (Pearson
product-moment correlation r = 0.461) between percent
malfunction of atrial grasping and ventricular grasping elec-
trodes for all physicians, and a small correlation between
atrial nongrasping and ventricular nongrasping electrodes (r
= 0.244). When physician specialty was held constant,
however, those correlations changed considerably. For sur-
geons, malfunction of grasping electrodes (atrial and ven-
tricular) was highly correlated (r = 0.649). When both the
number of physicians on the implant team and physician
specialty were held constant, the correlation coefficient for
malfunction of grasping electrodes increased to 0.689 for
solo surgeons and to 0.685 for team surgeons.
For nonsurgeons, on the other hand, the malfunction rate
for nongrasping atrial and ventricular electrodes was mod-
erately correlated (r = 0.428). In this case, however, the
correlation coefficient did not change when the number of
physicians on the implant team was held constant.
When the malfunction rate for atrial grasping electrodes
was analyzed with respect to differences among subgroups
of the sample, no significant differences were found because
very few respondents reported such malfunctions.
Although the malfunction rate for ventricular nongrasp-
ing electrodes showed differences by physician specialty,
volume and implantation team size, most of the differences
in the malfunction rate for atrial nongrasping electrodes
were observed among hospital types and for small subsets
of the sample.
For all pacemaker implanters, the malfunction rate for
atrial nongrasping electrodes was significantly higher in
medical schools and lower in public hospitals. Of physicians
working in a medical school, 27% experienced a malfunc-
tion rate of more than 5%, as opposed to 10% of those who
did not work in a medical school C~ = 10,23, p = 0.001).
For physicians working in a public hospital, the relation
was reversed. Six percent of those working in a public
hospital reported a malfunction rate of more than 5%, in
contrast to 15% of those not working in a public hospital
ci = 12.42. p = 0.001). Nonsurgeons in public hospitals
reported a lower incidence of malfunction than did surgeons.
Only 3% of those nonsurgeons reported a malfunction rate
of more than 5%, compared with 8% of surgeons.
When considering the entire sample, there were no dif-
ferences in the malfunction rate for atrial nongrasping elec-
trodes between those who did and those who did not work
in a hospital affiliated with a medical school. For certain
subgroups, however, the difference in malfunction rates was
statistically significant. Nonsurgeons, for example, reported
a malfunction rate of more than 5% in 25% of cases in a
medical school hospital and 9% in other types of institutions
ci = 5.50, p = 0.019). For team nonsurgeons, the rate
of malfunction was 31% C~ = 4.68, P = 0.03). Other
variables were considered for inclusion as indicators of the
quality of electrode implantation (for example, infection or
ulceration as an indication for electrode change), but the
number of responses to these survey items was insufficient
for statistical analysis.
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Usefulness of the manufacturer's sales representa-
tive. Significant differences were found in the attitudes of
physicians toward the assistance of the pacemaker manu-
facturer's sales representative at the operating table. Sur-
geons were slightly more favorably inclined than nonsur-
geons. Twenty-one percent of surgeons reported that they
found the sales representative's assistance "very" useful,
compared with 8% of nonsurgeons (1 = 18.87, p = 0.(01).
Teaching surgeons, however, found the sales representative
much less useful (18% of teaching surgeons and 35% of
nonteaching surgeons found the representative "moder-
ately" useful). This relation approached statistical signifi-
cance (1 = 6.90 and p = 0.075).
The most accurate discriminator of attitudes toward the
sales representative was the 1981 implant volume, with low
volume implanters reporting more favorable attitudes than
high volume implanters. Almost 34% of low volume im-
planters believed the sales representative was "very" or
"moderately" useful, whereas only 26% of high volume
implanters felt so positive (1 = 11.69, p = 0.009).
The relation between attitude toward the assistance of a
sales representative at the operating table and a hospital-
based practice approached statistical significance, with hos-
pital-based physicians demonstrating a considerably less
positive attitude than those whose practice was not hospital-
based. Almost 24% of the hospital-based physicians re-
ported that the sales representative's assistance at the op-
erating table was at least "moderately" useful, but 32% of
those whose practice was not hospital-based also reported
this level of usefulness (1 = 6.75, p = 0.081).
For nonsurgeons, attitude toward the sales representative
and two types of practice, private and hospital-based, yielded
statistically significant associations. Thirty-eight percent of
nonsurgeons in private practice found the representative's
assistance at least "moderately" useful, compared with 23%
of nonsurgeons in other types of practice (1 = 17.74, P
= 0.001). For hospital-based nonsurgeons, the sales rep-
resentative was not considered as useful. Only 22% reported
that the representative was at least "moderately" useful,
compared with 31% of nonhospital-based nonsurgeons (,I
= 12.89, P = 0.005).
Generally speaking, surgeons, low volume pacemaker
implanters and physicians with a hospital-based practice
were most likely to find the sales representative's assistance
at the operating table useful. Surgeons involved in research
and teaching were more likely to express a negative attitude
toward such assistance.
Discussion
Methodologic problems. Such problems were encoun-
tered from the very beginning of this study, because no
complete list of implanting physicians (our study popula-
tion) was available. The list had to be compiled by us, with
no guarantee that the list would be complete. Because we
had no way of determining whether our list was complete,
we were forced to assume that it was not. Without a com-
plete list of our target population, a probability sample was
not possible. Instead, we surveyed each physician on our
list, asking also for the names of other pacemaker implan-
ters. With this request, we hoped we would be able to add
to our list, making it more comprehensive, if not complete.
As is the case with any mailed questionnaire, the 765
respondents constituted a self-selected sample. Because we
had no data for nonrespondents, it was not possible to de-
termine whether they differed from the respondents in any
significant respect. It may be the case, for example, that
physicians in one region of the country were underrepre-
sented, or that very low volume implanters (for example,
those implanting fewer than five pacemakers per year) did
not feel that their data would contribute significantly to the
survey and so did not respond.
Although a self-selected sample may introduce a selec-
tion bias into the design and thus impose certain limitations
on the data, the results of research employing such a sam-
pling design should not be dismissed. Rather, one should
keep in mind the possibility of such limitations, especially
when considering the interpretation of results.
We were able to compare demographic information for
our respondents with the' 'best guess" of a major pacemaker
manufacturer's marketing staff. Our respondents appear to
be "representative" of the larger pacing community, in that
the demographic profile of our respondents matches the
manufacturer's profile rather closely on such variables as
specialty, number of years in medical practice, number of
years in pacing, pacing mode preference, type of practice
and number of implants per year. Nevertheless, our findings
must be viewed as estimations that may not be generalizable
to the entire population of pacemaker implanters.
Rate of pacemaker implantation. In the United States,
this rate has increased from about 309 implants per million
population in 1978 to 518 implants per million in 1981. We
estimate that, in 1981, there were 500,000 people in the
United States with cardiac pacemakers.
Indications for pacing. Sick sinus syndrome as an in-
dication for pacing has been increasing steadily over the
past few years. It appears that this indication has reached
its peak, however, as the expectation for 1985 is that it will
decrease by about 3% from its 1981 level to approximately
45%. This decrease may be explained by the growing per-
ception of the pacing public that pacing for sick sinus syn-
drome is not life-saving, as it is for complete heart block
with Adams-Stokes seizures and, therefore, is indicated only
to improve the quality of life. Furthermore, growing aware-
ness of the tendency to overuse pacemakers has been stressed
in a number of reports and commentaries (10). For these
reasons, one might expect more strict indications for pacing
to be applied. .
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Pacemaker type and mode usage. Dual-chamber and
atrial pacing . In 1981 , the type of pacemaker usage re-
flected continuingtechnological advances in cardiacpacing.
The use of dual-chamber and atrial pacing continued to
increase, and is expected to reach almost 37% of all pace-
maker implants by 1985 , with a corresponding decrease in
the use of VVI pacemakers. Some respondents (19%) felt
that their experience with dual-chamber and atrial systems
was insufficient to allow their use. These systems, never-
theless, now represent almost 10% of pacemaker implants.
As the use of dual-chamber and atrial systems increases, so
does the number of experienced physicians . We expect that
by 1985, the percent of "inexperienced" physicians will
have declined considerably, virtually excluding "insuffi-
cient experience" as a reason for not using dual-chamber
and atrial pacing systems.
An additional 20% of physicians did not implant dual-
chamber and atrial systems because the referring physician
had not requested them. We believe that, in part, this may
be a function of the physician's lack of familiarity with
dual-chamber pacing or a belief that single-chamber pacing
is simply good enough for almost everyone. Again, we
expect that an increasing familiarity withdual-chamber pac-
ing on the part of the physician will lead to an increase in
the use of such pacemakers.
Programmable versus nonprogrammable pacemakers.
Although almost all primary pacemakers implanted during
1981 were programmable (90%), 10% were nonprograrn-
mabie. Twelve physicians explained that they believednon-
programmable VVI pacemakers were adequate. Virtually
all physicians expressed confidence that rnultiprogramma-
bility was "clinically important" for patients younger than
70 yearsof age, but 34%reportedthat multiprogrammability
was either "unimportant" (7%) or only "slightly impor-
tant" (27%) for patients older than 70 years.
It is likely that the 10% of nonprogrammable pacemakers
were given to elderly patients for whom multiprogramma-
bility was viewed as relatively unimportant. The elderly are
often regarded as sedentary, inactive or even bedridden in-
dividuals, in whom rate support is the most that is needed
from a pacemaker. It is sometimes even suggested that the
elderly do not "need " dual-chamber pacemakers, and that
such advanced systems are " wasted" on them.
Reuse of lithium battery pacemakers. The majority of
respondents (82%) reported that they favored the reuse of
lithium battery pacemakers. These results support those of
an earlier smaller study in which 81 % of the American
physicians queried favored pacemakerreuse (Parsonnet and
Crawford, unpublished data). There appear to be enough
potential recipents of such pacemakers to justify a more
intensive investigation of methods of preparing normally
functioning pacemakers for reuse.
Implant experience and choice of pacemaker. The use
of multiprogrammable and dual-chamber pacemakers was
found to be related to the volume of a physician's implant
experience. It was evident that physicians working alone
and those implanting more than 30 pacemakers per year
used significantly more multiprogrammable pacemakers than
did team implanters and low volume implanters . If the num-
ber of pacemakers implanted in 1981 can be considered a
measure of implant experience, then the relation between
the use of multiprogrammable pacers and experience is clear.
It may be that only those physicians with considerable ex-
perience and confidence in their ability to implant a pace-
maker would work alone.
The relation between the use of DVI pacemakers and
experience was more direct. More DVI pacers were im-
planted by physicians who had been in practice for more
than 10 years than by those in practice 10 years or less.
DVI pacemakers were used more frequently by those in
private practice than by those not in private practice; mul-
tispecialty groupsused moreAAIpacemakers thandid other
practice types.
Electrode malfunction. Wechose the incidence ofearly
endocardial electrode malfunction (ventricular and atrial
grasping and nongrasping electrodes) as a measure of the
quality of electrode implantation , recognizing that this was
only a rough indicatorand only one aspect of quality. Vol-
ume and the quality of electrode implantation were found
to be directly related for nongrasping ventricular electrode
malfunction. The rate of malfunction decreased as volume
increased, regardless ofphysician specialty. But, within the
category of low volume implanters (30 or fewer implants
per year), surgeons experienced significantly more mal-
functions thandid nonsurgeons. In addition, solo implanters
experienced significantly fewer ventricular nongrasping
electrodemalfunctions than did team physicians. This lends
further support to a previous suggestion that only experi-
enced physicians, confident in their ability, would work
alone. When implant volume was held constant, however,
the relation between malfunction and the number of phy-
sicians on the implant team remained only for low volume
implanters. As expected, we found that, in general, as im-
plant volume (experience) increased. the malfunction rate
decreased.
Electrode malfunctions were more frequent in Veterans
Administration hospitals than in other types of hospitals ,
particularly for ventricularnongraspingelectrodes . This was
also true for nonsurgeons and team implanters working in
a Veterans Administration hospital, who reported a higher
malfunction rate than did surgeons and solo implanters. The
higher malfunction rate for ventricular nongrasping elec-
trodes implanted by teams provides additional support for
our interpretation of the greater experience and confidence
of the solo implanter.
Malfunctions ofatrialnongrasping electrodes were most
fr equent in medical schools and least frequent in public
hospitals. Nonsurgeons experienced higher malfunction rates
lACC Vol. 3, No.5
May 1984:1321·32
PARSONNET ET AL.
1981 c.s. PACING SVRVEY
1331
at a medical school affiliate; for team nonsurgeons, the
incidence of malfunctionwas even higher (31% experienced
a malfunction rate of more than 5%), Explanations for these
discrepancies are not apparent at this time,
For the patient requiring a pacemaker with either atrial
or ventricular nongrasping electrodes. the "best" implant
situation would appear to be a public hospital setting and a
solo nonsurgeon with a large implant volume. This com-
bination produced the lowest incidence of early endocardial
malfunction. The "worst case" appears to be implantation
by a team surgeon with a small implant volume, working
in a Veterans Administration hospital or a medical school.
A patient in the operating room under the care of a low
volume physician or a nonsurgeon with a hospital-based or
private practice may find that a manufacturer's sales rep-
resentative is also present. Physicians in these categories.
more than any others, were more likely to accept the sales
representative's assistance at the operating table.
Value of surveys of pacing trends and techniques.
Periodic surveys of pacing trends and techniques provide
valuable information and insights into the state of the art of
cardiac pacing. This medical specialty is growing so rapidly
that it seems that new pacemaker hardware, diagnostic tech-
niques and more sophisticated pacemaker programmers are
being marketed daily. Physicians implanting pacemakers
may find it difficult to keep up with these new developments
and know what equipment, procedures and techniques are
being used and found effective by their peers.
Periodic surveys of pacing trends and techniques are one
way in which physicians can share information with others
in their specialty, Internationally. it allows the United States
to share valuable information and experience with other
countries. Such sharing is important to physicians comitted
to cardiac pacing and to the quality of care and well-being
of the pacemaker patient.
The methodologic limitations inherent in this research
prohibit us from generalizing to the entire community of
pacemaker implanters. Because physicians involved in car-
diac pacing are not required to meet any particular national
or regional standards, complete any special course of train-
ing or apply for certificationfrom any board or organization.
a complete list of "pacemaker physicians" is unobtainable.
Had such a list been available. a stratified random (proba-
bility) sample would have been the design of choice. thus
permitting us to extrapolate and generalize to the entire
population of implanting physicians with far greater
confidence.
Futureneeds. Although the data we presentfor the United
States at each International Symposium are more complete
than those of the preceding survey and based on an increas-
ingly "representative" sample of physicians. major im-
provements in the methodology of such a large and com-
prehensive survey would make the data even more valuable.
This cannot be accomplished. however, unless a truly rep-
resentative sample can be drawn from the population. A
prospective data base, perhaps in the form of a national
pacemaker registry. would be a far more efficient method
of data collection. Retrospective survey analysis and its
inherent limitations would cease to be problematic because
data would be retrievable from a centralized source. Benefits
from such a system would accrue not only from ease of
retrieval. but also in terms of the accuracy and completeness
of the data.
The survey for 1981 has elicited important trends in the
practice of cardiac pacing. It is hoped that better ways to
obtain useful information on pacing practices will become
available by the time we begin data collection for the 1986
survey.
Summary and Conclusions
The 1981 United States Survey of Cardiac Pacing Prac-
tices has revealed several important facts and trends. as well
as expectations for the future. It has identified deficiencies
and problem areas that require attention, particularly the
rate of electrode malfunction. which has been assumed to
be an index of the technical skill of the implantingphysician
and thus a factor in the quality of patient care.
Although approximately half of the hospitals in the United
States performed pacemaker implantations, 75% of these
institutions did not have a special pacemaker department or
service and approximately 50% did not have specificwritten
guidelines governing surgical privileges for pacemaker im-
plantation. Of the approximately 5,600 implanting physi-
cians working in these hospitals, more were cardiothoracic
or general surgeons than were nonsurgeons (cardiologists
or internists). The rate of primary pacemaker implantation
had increased from 309 implants per million population in
1978 to 518 per million population in 1981 when there were
about 500,000 people in the United States with cardiac
pacemakers. I
Indications for pacing had changed. as had the equipment
and methods used for diagnosis and treatment. Sick sinus
syndrome, which represented about 23% of pacing indi-
cations in 1978, represented 48% in 1981, while pacing for
the treatment of tachyarrhythmias had begun to emerge as
a new indication (about 2%). Dual-chamber pacing had
grown in popularity to approximately 10% of implants and
is expected to increase to 37% by 1985, with a correspond-
ing decrease in the use of VVI pacemakers.
Between 1978 and 1981. the rate of usage of program-
mable pacemakers increased from 39 to 90%. yet nonpro-
grammable systems were still used in IOo/c of primary im-
plants, Many physicians did not take full advantage of pro-
gramming potentials as evidenced by the fact that almost
half of the programmable pacemakers implanted were not
reprogrammed within the first 3 months and 30o/c werenever
reprogrammed.
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Nevertheless, multiprogramrnability was considered
"clinically important" by many respondents. Troubleshoot-
ing of pacemaker problems and adjustments for physiologic
need were considered to be the most useful aspects 'of mul-
tiprogrammable systems. while "fine tuning" soon after
implantation was considered the least useful. These attitudes
may explain the frequent failure to reprogram some units,
with programming capabilities reserved for solving clinical
problems and not applied to refinements. such as the ex-
tension of pacemaker life by reducing the stimulus output
amplitude. Similarly, while multiprogrammability was con-
sidered important for patients under the age of 70 years, it
was felt to be relatively unimportant for older patients.
Evidence that such attitudes were justifiable was not ob-
tained from this survey.
. I
Our results show that the quality of lead implantation,
based on the frequency of early electrode malfunction, was
better in the hands of those who performed a high rather
than a low volume of pacemaker implantation. This was
also true of implanting physicians who worked alone as
compared with implanting teams, and for public and com-
munity hospitals as compared with Veterans Administration
hospitals and medical schools.
We thank Henry Kaynesof the MedtronicCorporation. Minneapolis. Min-
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